Telomere attrition
Telomeres are the protective caps on the ends of your chromosomes, and they shorten a little every time a cell divides, which is why they get sold as a clock you can read and reset. The reality is more humbling: longer is not simply better, the consumer tests are too noisy to act on, and nothing you can buy has been shown to lengthen them safely.
Don't buy a telomere test and don't take telomerase-activating supplements. Do the things that protect everything else: don't smoke, keep a healthy weight, sleep well, and favour aerobic and interval exercise alongside strength work, without expecting any of it to show up as a telomere number. The exception is lung scarring that runs in your family, or unexplained bone-marrow failure, where specialist telomere testing matters.
A clock that counts cell divisions
Telomere attrition is the second of the twelve hallmarks of aging, and its basic biology is well established. A telomere is a stretch of repetitive DNA, the same short sequence repeated thousands of times, at each end of a chromosome. It does no coding work; it is a disposable buffer. Every time a cell copies itself, the machinery that duplicates DNA can't quite finish the very tip, so a small piece is lost: typically about 50 to 200 DNA "letters" (base pairs) per division.[1]
The cap also tells the cell that a chromosome end is a natural end, not a break. A six-protein collar called shelterin folds the tip back into a protective loop so the cell's damage alarms ignore it.[2] A worn-out telomere stops looking capped and starts looking like the kind of DNA break covered under genomic instability, which trips the same damage response.
That is why normal human cells grown in a dish can divide only a finite number of times, a ceiling Leonard Hayflick described in the 1960s. When the caps reach a critical shortness, the cell enters replicative senescence, a permanent retirement in which it can no longer divide.[3] Senescence protects against cancer in the short term, but senescent cells linger and secrete inflammatory signals and tissue-degrading enzymes, which over decades feed the low-grade inflammation known as inflammaging.
Why you can't just switch the repair enzyme back on
An enzyme called telomerase adds the repeats back, but it is switched off in almost all adult body cells. It stays active mainly in the cells that give rise to eggs and sperm, in stem cells, and in immune cells when they are activated.[4] Even stem cells are not spared: blood-forming stem cells from adult bone marrow have shorter telomeres than those from fetal liver or umbilical-cord blood, a sign that their capacity to keep dividing also runs down with age.[5]
The reason it is switched off is cancer. Roughly 80 to 85% of human cancers switch telomerase back on, because limitless division is exactly what a tumour needs; most of the rest use a backup route called alternative lengthening of telomeres.[6] Shutting telomerase down in adult tissue is partly a tumour-suppression system: it caps how many times a rogue cell can multiply. Reactivating it to fight aging means loosening one of the body's built-in brakes on cancer, and that tension is the central problem of the field.
Longer is not better
The popular framing (short telomeres bad, long telomeres good, so lengthen them) is wrong, and the evidence against it is unusually clean. It comes from Mendelian randomization, which compares people by the telomere length they inherited at conception. That length is randomly assigned and fixed for life, which sidesteps most of the confounding that undermines ordinary observational studies.
Those studies show a trade-off. Genetically longer telomeres lower the risk of several wear-and-tear diseases: about 15% less coronary heart disease, much less idiopathic pulmonary fibrosis (a scarring lung disease), and less chronic kidney disease. They may lower Alzheimer's risk only very slightly, about 3%, the weakest signal of the group. The same inherited advantage raises the risk of many cancers, including glioma, and also of high blood pressure, metabolic syndrome and multiple sclerosis.[7] A scan of more than 1,000 health outcomes in about 400,000 UK Biobank participants, rechecked in a separate Finnish population, found the same split: lower risk for five conditions, higher risk for 23 others, mainly cancers.[8]
There is a human natural experiment for the long end, too. People who inherit a faulty copy of POT1, a gene that normally restrains telomere lengthening, carry unusually long telomeres, and in affected families they develop a wide range of tumours, including lymphoma and other blood cancers.[9] In UK Biobank, carriers had about eight times the usual risk of lymphoid blood cancers, an estimated 45% having developed one by age 80.[10]
The net effect on lifespan is close to a wash. A Mendelian-randomization analysis of about half a million UK Biobank participants found no clear effect of inherited telomere length on lifespan in either sex, though it could only have detected an effect of about 0.8 years or more, and lifespan was measured through parents' age at death. In women, longer telomeres went with slightly worse survival to late middle age, about three months less; the authors say this may be chance.[11] Measured telomere length also shows only a small overall effect: in about 470,000 UK Biobank adults, shorter telomeres carried only about 8% higher risk of death for each standard-deviation step shorter (a standard deviation is the typical spread between people), with cancer cutting both ways.[12]
Where longer telomeres may help is healthspan, the years lived before a first major chronic disease. A genetic analysis drawing on about 300,000 UK Biobank participants found that people who inherited longer telomeres went longer before a first diagnosis of cancer, heart attack, heart failure, stroke, dementia, diabetes or chronic lung disease, or before death; the authors call this consistent with a possible effect rather than proof.[13] That study did not look at lifespan, so "better healthspan, unchanged lifespan" comes from setting two separate studies side by side. The body's optimum is a balance: long enough to keep tissues regenerating, short enough to retire dangerous cells.
What wears them down: inflammation is a suspect, not a finding
The appealing story is that lifestyle acts on telomeres one step upstream, by raising or lowering chronic inflammation. It is worth taking seriously, but the evidence for it is weak.
It rests mainly on one analysis of 7,096 adults in the long-running US national health survey (NHANES). Blood C-reactive protein (CRP), the standard marker of systemic inflammation, was linked to shorter telomeres, most strongly in younger and middle-aged adults, while smoking, physical activity, sex, race and socioeconomic status connected to telomeres almost entirely through CRP. The few dietary measures with a direct link mostly went the "wrong" way: higher fibre and caffeine intake and higher blood gamma-tocopherol (a form of vitamin E) went with shorter telomeres.[14] A single snapshot in time cannot show what causes what.
Other evidence has not confirmed it. A genetic study of 41 inflammatory signalling molecules found at most weak links to telomere length,[15] another found some links running from telomeres to inflammation rather than the other way,[16] and in a two-year trial in healthy adults, calorie restriction did not slow telomere loss compared with normal eating.[17] People living with HIV tend to have shorter telomeres, plausibly from constant immune activation, but those studies are of very low quality.[18]
Sleep and stress fit the picture loosely. Across 19 pooled observational studies, poorer sleep quality went with roughly 24% higher odds of telomere shortening, and more time awake at night with about 28% higher odds; no trial has tested whether better sleep protects telomeres.[19] In a randomised trial in adults aged 65 and over, 18 months of meditation training made no difference to telomere length (more under mindfulness and meditation).[20]
The practical advice does not change: not smoking, a healthy weight, good sleep and managing stress are worth doing for many reasons. Just don't expect them to show up as a telomere number.
Diet and exercise: small signals, mostly observational
Diet works mostly as a pattern. Higher adherence to a Mediterranean dietary pattern is associated with longer telomeres in large cohorts, though almost all of this is observational. In the Nurses' Health Study, the overall diet score tracked longer telomeres but none of its individual components did on its own.[21] Pooling eight cross-sectional studies, the effect was small, not significant in men, and lost significance in women once other factors were fully accounted for.[22] A 69-person pilot within the PREDIMED-Plus trial, in adults with metabolic syndrome, saw telomeres measure longer after a year on two versions of a Mediterranean diet, but with no comparison diet it cannot show the diet caused that.[23] Sugar-sweetened drinks, refined carbohydrate and processed meat track with higher inflammation and shorter telomeres.[24]
Among everyday supplements, vitamin D is the one with a randomised signal. In a four-year telomere substudy of the VITAL trial, about 1,000 US adults aged 50 and over on 2,000 IU of vitamin D3 a day lost about 140 base pairs less than those on placebo, a difference only just statistically significant, while fish oil made no difference.[25] That is slower loss, not lengthening, from one substudy using a cheap but imprecise test, and nobody has shown it changes any health outcome.
Exercise might help a little, and the type may matter. In a six-month randomised trial in previously inactive adults, aerobic endurance training and high-intensity interval training (HIIT) each raised telomerase activity two- to three-fold and lengthened telomeres, while resistance training did neither.[26] Pooled trials are messier. A 2024 meta-analysis of nine trials in healthy adults found no clear overall effect;[27] a 2025 analysis of 16 randomised trials found a modest benefit, apparently only in programmes lasting at least 16 weeks, with telomerase rising on aerobic but not clearly on resistance training.[28] The studies disagree a lot and most used noisy measurements, so this is a small benefit held with low confidence. It is not a reason to lift less: resistance training remains essential for muscle, bone and insulin sensitivity, so pair it with aerobic and interval work.
Don't buy a telomere test
A single number for biological age is an appealing idea, which is why direct-to-consumer telomere tests exist. For an individual, they are close to useless. Almost all cheap kits use a DNA-amplification method (the polymerase chain reaction, PCR) that reports an average signal across millions of mixed cells. When ten laboratories measured the same blinded samples, PCR results varied by about 20% from lab to lab, and absolute numbers could not be compared directly between labs, though most labs ranked the samples in a similar order.[29] There is no agreed reference range, and the year-to-year change in one person is swamped by that noise. Even measured carefully in research cohorts, blood telomere length predicted death worse than DNA-methylation "clocks".[30] The method comparison and the clinical-grade alternative are on Telomere length test.
Some of the most prominent advocacy for telomere testing comes from researchers with a commercial stake: María Blasco, one of the field's leading telomere biologists, co-founded Life Length, a company that sells telomere measurement, an interest she has disclosed.[31] That doesn't make the science wrong, but it is a reason to discount marketing that sells a noisy number as a readout of your aging. Spend the money on high-sensitivity CRP, fasting insulin and a lipid panel instead.
Lengthening telomeres on purpose: unproven, and the cancer question is open
Everything here rests on mouse data or small, seller-funded human trials, and the long-term cancer question is unresolved in humans for every item.
TA-65, a supplement purified from the Astragalus plant and sold as a telomerase activator, has one small human trial that measured telomeres: in 117 adults aged 53 to 87 who carried cytomegalovirus, a common chronic virus, the low dose reported longer average telomeres than placebo and the higher dose showed no significant change. Every author was funded by, employed by or consulting for the company that sells it.[32] A second randomised trial, also maker-funded, in 90 heart-attack survivors over 65 missed its main goal and did not measure telomeres.[33] Its only cancer-safety study, in ultraviolet-exposed mice and paid for by the manufacturer, found no overall difference in tumours, but more tumours of 2 mm or larger in one group at two time points (one only borderline), and was too small to rule out harm.[34] It is not a recommendable intervention.
Gene therapy delivering the telomerase gene eased some signs of neurodegeneration in mice bred to have short telomeres, with no rise in cancer.[35] That is specific to short-telomere neurodegeneration, in mice; human safety is entirely unestablished.
Senolytics take a different route, clearing the senescent cells that short telomeres produce. They are in early human trials and not a routine intervention; see cellular senescence and geroprotectors.
Tellingly, the telomerase drug that has gone furthest in trials does the opposite: imetelstat blocks the enzyme to hold back a blood cancer (lower-risk myelodysplastic syndrome). In its main company-funded trial, 40% of patients went at least 8 weeks without a transfusion, against 15% on placebo, at the cost of frequent, severe drops in blood counts.[36]
When telomeres fail early
The clearest proof that telomere maintenance matters for human health comes from rare inherited diseases in which it fails. In dyskeratosis congenita and related telomere biology disorders, faulty telomere-maintenance genes make the caps shorten far too fast. Patients face an increased risk of bone-marrow failure, lung scarring (pulmonary fibrosis) and several cancers,[37] in effect accelerated aging in the tissues that depend on constant renewal.
This is where testing earns its place. In adults, faulty telomere maintenance is the most common single-gene cause of inherited lung fibrosis,[38] so people with lung scarring that runs in the family, or with unexplained bone-marrow failure, should ask a specialist about genetic testing, because the condition can affect other organs that need monitoring. The test should be the clinical-grade one, flow-FISH (a cell-by-cell fluorescence method): in people being tested for a suspected telomere disease, the cheap PCR method flagged only 40% of those with telomeres below the tenth percentile, against 80% for flow-FISH.[39] Danazol, a synthetic male hormone tested in these patients, improved blood counts in about four in five people with telomere-driven marrow failure,[40] but the benefit faded once the drug stopped,[41] and in telomere-related lung scarring side effects alone made more than a third of patients stop.[42] It is a specialist treatment for a rare disease, not an anti-aging drug.
Further reading
- López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell 2023.[43]
- Iskandar M, et al. A review of telomere attrition in cancer and aging: current molecular insights and future therapeutic approaches. Cancers (Basel) 2025.[44]
- Chen B, et al. Association between genetically determined telomere length and health-related outcomes: a systematic review and meta-analysis of Mendelian randomization studies. Aging Cell 2023.[45]
- Schooling CM, et al. Biological aging and lifespan in men and women using a Mendelian randomization study. Hum Genomics 2025.[46]
- Feng B, et al. Genetically proxied leukocyte telomere length and epigenetic age acceleration in relation to healthspan: a Mendelian randomization study. Ann Hum Genet 2026.[47]
- Tedaldi AM, et al. Diet, lifestyle and telomere length: using copula graphical models on NHANES data. Aging (Albany NY) 2025.[48]
- Crous-Bou M, et al. Mediterranean diet and telomere length in Nurses' Health Study: population based cohort study. BMJ 2014.[49]
- Werner CM, et al. Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length. Eur Heart J 2019.[50]
- Sánchez-González JL, et al. Effects of physical exercise on telomere length in healthy adults: systematic review, meta-analysis, and meta-regression. JMIR Public Health Surveill 2024.[51]
- Martin-Ruiz CM, et al. Reproducibility of telomere length assessment: an international collaborative study. Int J Epidemiol 2015.[52]
- Bär C, Blasco MA. Telomeres and telomerase as therapeutic targets to prevent and treat age-related diseases. F1000Res 2016 — note the disclosed commercial interest in telomere measurement.[53]
- Salvador L, et al. A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo controlled study. Rejuvenation Res 2016.[54]